These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10553710)

  • 1. Cost effectiveness of quinolones in hospitals and the community.
    Davey P
    Drugs; 1999; 58 Suppl 2():71-7. PubMed ID: 10553710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating fluoroquinolones into the hospital formulary.
    Bertino JS
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):273S-283S. PubMed ID: 11642692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic considerations on the use of the new fluoroquinolones in the hospital setting].
    Maggiolo F; Pellegata G; Marchetti G; Suter F
    G Ital Chemioter; 1989; 36(1-3):101-4. PubMed ID: 2488906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
    Walters DJ; Solomkin JS; Paladino JA
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance: cost and containment.
    Coast J; Smith RD
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):241-51. PubMed ID: 15482119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, microbiology, cost: interrelated problems for the 1990s that impact on the use of fluoroquinolone antimicrobial agents.
    Neu HC
    Am J Med; 1992 Apr; 92(4A):2S-7S. PubMed ID: 1580269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrofloxacin in salmonids.
    Bowser PR; Babish JG
    Vet Hum Toxicol; 1991; 33 Suppl 1():46-8. PubMed ID: 1926748
    [No Abstract]   [Full Text] [Related]  

  • 10. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic aspects of pneumococcal pneumonia: a review of the literature.
    De Graeve D; Beutels P
    Pharmacoeconomics; 2004; 22(11):719-40. PubMed ID: 15250750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of oral fluoroquinolones in nursing home patients.
    File TM; Tan JS
    Drugs Aging; 1992; 2(4):310-29. PubMed ID: 1504445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial therapy: pharmacoeconomic aspects].
    Popova IuN; Belousov DIu; Omel'ianovskiĭ VV
    Antibiot Khimioter; 2002; 47(9):24-30. PubMed ID: 12619518
    [No Abstract]   [Full Text] [Related]  

  • 16. The quinolones and renal infection.
    Ronald A
    Drugs; 1999; 58 Suppl 2():96-8. PubMed ID: 10553715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of quinolone resistance: Europe and North and South America.
    Goldstein FW; Acar JF
    Drugs; 1995; 49 Suppl 2():36-42. PubMed ID: 8549361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolones: clinical use and formulary considerations.
    Cunha BA
    Adv Ther; 1998; 15(5):277-87. PubMed ID: 10345149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolone activity against anaerobes.
    Appelbaum PC
    Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oral fluoroquinolones as an alternative to traditional parenteral therapy for patients with serious infections.
    Ball P
    Clin Invest Med; 1989 Feb; 12(1):69-70. PubMed ID: 2920483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.